Scientists train Patients' own cells to fight deadly skin cancer
NCT ID NCT05098184
Summary
This early-stage study tests whether a personalized immune cell therapy can help control advanced melanoma. Doctors take immune cells from a patient's own tumor, grow large numbers of them in a lab, then infuse them back into the patient after mild chemotherapy. The study aims to see if this approach is safe and can shrink tumors in people who have run out of standard treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Tenth People's Hospital
RECRUITINGShanghai, China
Contact Phone: •••-•••-••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.